F2G
@F2Gltd
F2G is a clinical-stage biopharmaceutical company focused on the discovery & development of novel therapies to treat life-threatening invasive fungal infection.
ID:1579863059862093824
https://www.f2g.com/ 11-10-2022 15:55:07
44 Tweets
45 Followers
131 Following
Our CMO, Dr. John Rex, joined industry experts in sharing insights on the threat posed by #FungalInfections and the need for innovative treatments to combat these diseases effectively in the latest InfectiousDiseaseSE. Read more: brnw.ch/21wF2lK #FireExtinguishersOfMedicine
Our Global Head of Medical Affairs, Dr. Emma Harvey was featured in BioPharma-Reporter’s “Women in Science” series. Dr. Harvey delves into her career journey, offering valuable insights & guidance for aspiring young women & carers in science. Read more: brnw.ch/21wERK3
Today, we presented the full data set from a Phase 2b study of our oral #antifungal in patients with invasive #fungalinfections who have limited or no treatment options at TIMM2023, Athens, Greece. Read press release here for more details: brnw.ch/21wDJDD
F2G is committed to making a difference in the #antifungal treatment landscape and is excited to be at the Trends in Medical Mycology (TIMM2023, Athens, Greece) 2023 Congress. We look forward to welcoming you to our booth #7 where you can learn more about F2G!
The TIMM2023, Athens, Greece kicks off today! We are excited to announce that 10 abstracts on our #antifungal candidate have been accepted. We look forward to engaging and sharing research findings with you. Check out the programme lineup here: brnw.ch/21wDHUj
We are pleased to sponsor TIMM2023, Athens, Greece. TIMM is one of the largest global forums in which scientists and clinicians from all over the world present their latest advances and research findings in medical mycology. Register at: brnw.ch/21wDGtq
We’re pleased to announce that F2G is a The Creative Floor Awards winner in the Best Exhibit (HCP) category for our IDWeek 2022 booth exhibit, 'The Fine Art of Fighting', in partnership with NEON and Poretta & Orr, Inc.. Visit our booth #508 at #IDWeek2023 to check out the exhibit.
Today’s #FungalDiseaseAwarenessWeek theme highlights the impact of climate change on fungal diseases. #ValleyFever is on the rise in the U.S., and climate change could be helping spread the fungus. Learn more about the connection between the two: brnw.ch/21wCQ78 #FDAW
Today marks the beginning of #FungalDiseaseAwarenessWeek . As part of #FDAW , the CDC is partnering with the World Health Organization (WHO) for a webinar covering a global view on the challenges and opportunities of #FungalDiseases . Click for webinar details: brnw.ch/21wCGAF
Check out this recent article by Dominique Mosbergen in the The Wall Street Journal discussing the rise in drug-resistant #fungalinfections , challenges developing new antifungal drugs, and the need to preserve their efficacy. Read the full article here: brnw.ch/21wCacp
August is #ValleyFever Awareness Month in California. You get Valley Fever by inhaling microscopic fungal spores from Coccidioides in the air. In 2019, there were >20,000 cases reported to the CDC. Learn more here: brnw.ch/21wC8xX
Emma Harvey, our global head of medical affairs, was featured in Labiotech.eu sharing insight on what the UKSHA 10-year science strategy could mean for the #LifeScience industry. Read more here: brnw.ch/21wBXhf